J, B., R, A., A, V., & S, C. (2026). Long-term real-world persistence of guselkumab in patients with moderate-to-severe psoriasis.
Chicago Style CitationJ, Borrás-Blasco, Alcala R, Valcuende-Rosique A, and Cornejo S. Long-term Real-world Persistence of Guselkumab in Patients With Moderate-to-severe Psoriasis. 2026.
MLA CitationJ, Borrás-Blasco, Alcala R, Valcuende-Rosique A, and Cornejo S. Long-term Real-world Persistence of Guselkumab in Patients With Moderate-to-severe Psoriasis. 2026.
Warning: These citations may not always be 100% accurate.